HSCS HeartSciences Inc.

Nasdaq heartsciences.com


$ 2.53 $ -0.62 (-20.06 %)    

Friday, 21-Nov-2025 14:17:30 EST
QQQ $ 596.77 $ 9.44 (1.61 %)
DIA $ 465.47 $ 6.00 (1.31 %)
SPY $ 664.37 $ 9.36 (1.43 %)
TLT $ 89.34 $ -0.32 (-0.36 %)
GLD $ 376.00 $ 2.01 (0.54 %)
$ 2.91
$ 3.09
$ 2.45 x 47
$ 2.53 x 100
$ 2.07 - $ 2.95
$ 2.53 - $ 6.47
15,186
na
7.7M
$ 2.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-11-2025 07-31-2025 10-Q
2 07-24-2025 04-30-2025 10-K
3 03-13-2025 01-31-2025 10-Q
4 12-16-2024 10-31-2024 10-Q
5 09-12-2024 07-31-2024 10-Q
6 07-29-2024 04-30-2024 10-K
7 03-14-2024 01-31-2024 10-Q
8 12-14-2023 10-31-2023 10-Q
9 09-14-2023 07-31-2023 10-Q
10 07-18-2023 04-30-2023 10-K
11 03-16-2023 01-31-2023 10-Q
12 12-15-2022 10-31-2022 10-Q
13 09-12-2022 07-31-2022 10-Q
14 07-29-2022 04-30-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ascendiant-capital-maintains-buy-on-heartsciences-lowers-price-target-to-9

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...

 heartsciences-q1-eps-158-beats-209-estimate-sales-1900m

HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(...

 heartsciences-announces-25m-offering

-SEC Filing

 heart-test-laboratories-q4-eps-186-beats-225-estimate-sales-4350m

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate ...

 heartsciences-signs-first-commercial-customer-westcliffe-health-innovations-uk-for-its-ai-powered-myovista-insights-platform

HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence ("...

 ascendiant-capital-maintains-buy-on-heartsciences-lowers-price-target-to-14

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...

 maxim-group-reiterates-buy-on-heartsciences-maintains-12-price-target

Maxim Group analyst Allen Klee reiterates HeartSciences (NASDAQ:HSCS) with a Buy and maintains $12 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION